COREG MR Versus TOPROL-XL On Reduction Of Microalbuminuria In Patients With Hypertension And Microalbuminuria

Stopped early · Phase 3

Conditions studied: Heart Failure, Congestive and Microalbuminuria

In brief

This study was designed to determine whether COREG MR is more effective than TOPROL-XL in reducing microalbuminuria in type 2 diabetic or non-diabetic patients with high blood pressure and microalbuminuria.

Key facts

Study ID

NCT00123903

Run by

GlaxoSmithKline

People needed

1220

Starts

2005-07-01

Expected to finish

2006-05-01

Last updated by the study team

2017-01-18

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Documented history of hypertension.
• Must have been taking an ACE (angiotensin converting enzyme) inhibitor either alone or as part of an antihypertensive regimen for at least 8 weeks.
• Persistent microalbuminuria.

You may not qualify if…

• History of heart attack, stroke, congestive heart failure, arrhythmia, type 1 or uncontrolled type 2 diabetes mellitus, liver or renal disease.
• Has been taking any non-ocular beta-blockers for any indication within three months prior to Pre-screening.

Where it is running

• GSK Investigational Site — Mobile, Alabama, United States
• GSK Investigational Site — Phoenix, Arizona, United States
• GSK Investigational Site — Fullerton, California, United States
• GSK Investigational Site — Inglewood, California, United States
• GSK Investigational Site — Los Angeles, California, United States
• GSK Investigational Site — Mission Viejo, California, United States
• GSK Investigational Site — Oakland, California, United States
• GSK Investigational Site — Redondo Beach, California, United States
• GSK Investigational Site — Colorado Springs, Colorado, United States
• GSK Investigational Site — Hollywood, Florida, United States
• GSK Investigational Site — Miami, Florida, United States
• GSK Investigational Site — Miami, Florida, United States
• GSK Investigational Site — Pembroke Pines, Florida, United States
• GSK Investigational Site — Sarasota, Florida, United States
• GSK Investigational Site — Tampa, Florida, United States
• GSK Investigational Site — Decatur, Georgia, United States
• GSK Investigational Site — Chicago, Illinois, United States
• GSK Investigational Site — Chicago, Illinois, United States
• GSK Investigational Site — Melrose Park, Illinois, United States
• GSK Investigational Site — Avon, Indiana, United States
• GSK Investigational Site — Elkhart, Indiana, United States
• GSK Investigational Site — Evansville, Indiana, United States
• GSK Investigational Site — Evansville, Indiana, United States
• GSK Investigational Site — Indianapolis, Indiana, United States
• GSK Investigational Site — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.